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Cancer-associated fibroblasts (CAFs) are important
at all tumor stages. CSL/RBPJk suppresses the
gene expression program leading to CAF activation
and associated metabolic reprogramming, as well
as autophagy. Little is known about CSL protein turn-
over, especially in the tumor microenvironment. We
report that, in human dermal fibroblasts (HDFs), con-
ditions inducing autophagy—often found in tumor
stroma—down-regulate CSL protein levels but do
not affect its mRNA levels. Genetic or pharmacologic
targeting of the autophagic machinery blocks CSL
down-modulation. Mechanistically, endogenous
CSL associates with the autophagy and signaling
adaptor p62/SQSTM1, which is required for CSL
down-modulation by autophagy. This is functionally
significant, because both CSL and p62 levels are
lower in skin cancer-derived CAFs, in which auto-
phagy is increased. Increasing cellular CSL levels
stabilizes p62 and down-modulates the autophagic
process. We reveal here an autophagy-initiated
mechanism for CSL down-modulation, which could
be targeted for stroma-focused cancer prevention
and treatment.
INTRODUCTION
Autophagy is a homeostatic metabolic mechanism responsible
for bulk degradation of cellular molecules and organelles (Levine
and Kroemer, 2008; Mizushima and Komatsu, 2011). Although
key for cancer initiation and progression (White, 2015), the
involvement of autophagy in the stromal compartment, and in
particular in cancer-associated fibroblast (CAF) activation, has
been investigated to a limited extent. Autophagy-activating con-
ditions, such as low nutrients, increased reactive oxygen species
(ROS) (Pavlides et al., 2010), and hypoxia (Martinez-Outschoorn
et al., 2010), are often found in cancer stroma (Zhao et al., 2013).
In this context, a reverse Warburg effect concept was intro-
duced, whereby activation of stromal autophagy and mitophagy
by hypoxia (Martinez-Outschoorn et al., 2010), senescence3108 Cell Reports 24, 3108–3114, September 18, 2018 ª 2018 The A
This is an open access article under the CC BY-NC-ND license (http://(Capparelli et al., 2012a), and autophagy effectors (Capparelli
et al., 2012b) leads to a glycolytic switch producing high-energy
intermediates, such as ketones and lactate, which impinge on
cancer cells promoting tumor growth and metastasis (Marti-
nez-Outschoorn et al., 2011, 2017).
The CSL/RBPJk (CSL) protein, a transcriptional repressor
converted byNOTCH into an activator, is key for negative control
of CAF activation. Deletion of Csl in the mesenchymal skin
compartment of mice or CSL down-modulation in primary hu-
man dermal fibroblasts (HDFs) results in the activation of a
CAF phenotype (Hu et al., 2012; Procopio et al., 2015). We
have shown that CSL loss in HDFs leads to up-regulation of
the pro-autophagy kinase ULK3, which is responsible for CAF
activation and concomitantly activates autophagy and amitoph-
agy-associated glycolytic switch (Goruppi et al., 2017).
The adaptor protein sequestosome 1 (p62/SQSTM1) plays a
key role in the autophagic process, functioning as cargo for spe-
cific proteins, including key transcription factors like SMADs and
nuclear factor kB (NF-kB), to be degraded in autophagosomes,
with p62 being degraded in the process (Moscat and Diaz-
Meco, 2009). p62 is down-regulated in the stroma of several can-
cer types, and its down-modulation has been implicated in the
metabolic reprogramming of stromal CAFs through an
mTORC1/Myc pathway regulating interleukin-6 (IL-6) production
(Valencia et al., 2014). In the liver, loss of p62 activates stromal
stellate cells, resulting in higher inflammation and fibrosis due
to impaired vitamin D receptor (VDR) signaling with p62 func-
tioning in this context as a transcriptional co-regulator (Duran
et al., 2016). Little is known about the control of CSL protein turn-
over, particularly in the tumor microenvironment. We report here
a so far unsuspected interplay between p62 and CSL. p62 and
CSL proteins associate physically, and upon induction of auto-
phagy, CSL is down-modulated in stromal fibroblasts through
a p62-dependent mechanism. This is functionally significant,
because CSL and p62 are concomitantly down-modulated in
clinically derived CAFs and increased CSL stabilizes p62,
decreasing the expression of autophagic genes.
RESULTS
Loss of Csl repressive function in mouse dermal fibroblasts and
HDFs leads to CAF activation (Hu et al., 2012; Procopio et al.,
2015). Concomitantly, we showed that CSL down-modulationuthor(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Autophagy Down-Modulates CSL
Protein
(A) CSL is down-regulated by autophagy. Immu-
noblot analysis was performed for four HDF strains
that were untreated (untr.), serum starved (s.f.), or
treated with the KU0063794 mTOR inhibitor
(mTOR-i; 10 mM) or a mitochondria-uncoupling
agent (CCCP; 5 mM) for 24 hr to induce autophagy.
Blots were sequentially probed with antibodies
against CSL, LC3- to monitor autophagic pro-
cessing, and with anti g-Tubulin (TUBULIN) or
b-Actin (ACTIN), as equal loading. The identifier of
the operator and a progressive number classify
each primary HDF strain (e.g., SAN3), and a list of all
the cells used is provided in Key Resources Table.
(B) Immunofluorescence analysis with anti-CSL
antibodies (green), phalloidin (red), and DAPI (blue)
of two HDF strains treated as in (A). Phalloidin and
DAPI counterstained the cytoskeleton and the
nuclei, respectively. Scale bar, 40 mm.
(C) Autophagy down-modulates CSL protein inde-
pendently of its RNA levels. RT-qPCR analysis of
CSL expression, normalized to b-actin, of two HDF
strains (SAN4 and SAN5) treated as in (A).
(D) CSL down-modulation results in the upregula-
tion of CAF effector genes. RT-qPCRanalysis of the
indicated CAF effector gene expression, normal-
ized to b-actin, of two HDF (SAN2 and SAN3)
treated as in (A).
Mean ± SEM; n (experiments) = 3; NS, not signifi-
cant; *p% 0.05, two-tailed unpaired t test.increases HDF autophagy, mitophagy, and associated meta-
bolic reprogramming (Goruppi et al., 2017). Previous evi-
dence reported that pro-carcinogenic stimuli such as ultraviolet
A rays (UVAs) and smoke extract exposure, which induce
autophagy (Ratovitski, 2011; Sample et al., 2017), similarly
down-regulate CSL (Menietti et al., 2016). Using specific exper-
imental conditions activating different types of autophagy, we
determined that all inducers of autophagy affected CSL protein
levels. Conditions such as serum starvation, inhibition of
mTOR activity, and mitochondria uncoupling down-regulated
CSL protein levels in HDFs, as seen by immunofluorescenceCell Reportand immunoblotting (Figures 1A and 1B).
Decreased CSL protein levels are not
a secondary consequence of reduced
transcription, because CSL mRNA was
not concomitantly down-modulated after
these treatments (Figure 1C), and they
are functionally significant, because we
observed a simultaneous upregulation of
CAF effector genes such as cyclooxyge-
nase-2 (PTGS2), tenascin-C (TNC), and
IL6 (Figure 1D).
To assess whether CSL protein down-
modulation is a consequence of increased
autophagy, we employed several comple-
mentary approaches. 3-methyladenine
(3MA) blocks early steps of the autophagic
process by targeting type III phosphatidyli-nositol 3-kinases (Klionsky et al., 2016). Treatment of HDFs with
this inhibitor counteracted the down-modulation of CSL by
various inducers of autophagy while resulting in an accumulation
of p62/SQSTM1 (p62), a cargo protein that is degraded by auto-
phagic flux (Klionsky et al., 2016) (Figure 2A). As a more specific
approach, we targeted the ATG5 gene, which is essential for au-
tophagosome elongation (Klionsky et al., 2016; Kuma et al.,
2004). Down-modulation of the CSL protein by the various
inducersof autophagywassuppressed inHDFswith small hairpin
RNA (shRNA)-mediated down-modulation of ATG5, as well as
in mouse embryo fibroblasts (MEFs) with Atg5 gene disruptions 24, 3108–3114, September 18, 2018 3109
Figure 2. CSL Protein Down-Modulation Re-
quires Autophagy
(A) Pharmacologic inhibition of autophagy blocks
CSL down-modulation. Immunoblot analysis was
performed for two HDF strains treated as indicated in
Figure 1A for 24 hr and further incubated with 5 mM
3-methyladenine (3MA) for 8 hr to inhibit autophagy,
in parallel with vehicle alone (DMEM). The blot was
sequentially probed with antibodies against CSL,
p62, and b-ACTIN.
(B and C) Targeting of autophagy-essential gene
ATG5 blocks CSL down-modulation. Immunoblot
analysis was performed for two HDFs plus/minus
shRNA-mediated ATG5 gene silencing (B) or for
mouse embryo fibroblasts (MEFs) plus/minus Atg5
gene disruption (+/+ and /) (Kuma et al., 2004) (C)
that were either left untreated (untr.) or treated with
various pro-autophagic stimuli as in Figure 1A. Blots
were sequentially probed with antibodies against
CSL, ATG5, and ACTIN as equal loading.(Figures 2B and 2C). Thus, pro-autophagic stimuli down-modu-
late CSL protein levels through a mechanism requiring the auto-
phagic machinery.
p62 has a cargo function for several transcription factors
(Johansen and Lamark, 2011; Katsuragi et al., 2015), and an
attractive possibility was that it physically associates with CSL.
Proximity ligation assays (PLAs) provide a sensitive method for
detection of protein-protein associations at the cellular level
(So¨derberg et al., 2006). We found punctate signals (puncta)
resulting from the juxtaposition of anti-CSL and anti-p62 anti-
bodies in HDFs (Figures 3A and S1A), with the number of these
puncta being significantly reduced by CSL silencing as a speci-
ficity control (Figures 3B and S1B). More directly, we found that
endogenous p62 andCSLwere recovered by co-immunoprecip-
itation from HDFs (Figures 3C and S1C). Similar positive results
were obtained after co-immunoprecipitation of the two recombi-
nant proteins, demonstrating a direct interaction between the
two (Figure 3D).
The p62 protein contains several functional regions,
including an N-terminal oligomerization domain (protein
homo/hetero dimerization domain of p62 [PB1]), a light-chain
3 (LC3)-interacting region (LIR), and a C-terminal ubiquitin-
association (UBA) domain (Johansen and Lamark, 2011; Mos-
cat and Diaz-Meco, 2009). Co-immunoprecipitation experi-
ments of HEK293 cells co-transfected with expression vectors
for CSL, together with p62 deletion mutants disrupting these
various regions (Bjørkøy et al., 2005), showed that binding of
CSL was unaffected by all p62 mutations except the one
with a deletion of the 50 amino acid C-terminal domain,
more directly implicated in the delivery of proteins to degrada-3110 Cell Reports 24, 3108–3114, September 18, 2018tion (Johansen and Lamark, 2011; Ko-
matsu et al., 2007) (Figure 3E).
To assess whether CSL-p62 interaction is
of functional importance for CSL degrada-
tion, we tested whether p62 is required for
CSL down-modulation by autophagy
stressors. We found that down-modulationof CSL protein levels by autophagy stressors was suppressed
in both HDFs or MEFs with small interfering RNA (siRNA)- or
shRNA-mediated p62 silencing (Figures 4A and 4B). Similarly,
CSL down-modulation by autophagy stressors was blocked in
MEFs with p62 gene disruption (Figures 4C and 4D). The preced-
ing findings are of likely clinical significance for HDF to CAF acti-
vation, in which we showed that CSL down-modulation induces
autophagy (Goruppi et al., 2017). Immunoblot analysis showed
parallel down-modulation of CSL and p62 levels in a set of skin
squamous cell carcinoma (SCC)-derived CAF strains versus
non-matched HDFs (Figure 5A).
Functionally, increased CSL expression by lentiviral vector
infection of HDFs resulted in concomitantly enhanced p62 levels
under basal conditions and after autophagy activation by serum
starvation, in both the presence and the absence of bafilomycin
A1, which prevents lysosomal acidification step of the autopha-
gic flux (Figure 5B). On this line, we found that CSL overexpres-
sion was paralleled by the suppression of three autophagy
marker genes (Figure 5C) that we have shown to be up-regulated
by CSL loss in HDFs (Goruppi et al., 2017).
Decreased p62 is causative to CAF activation in multiple sys-
tems (Duran et al., 2016; Valencia et al., 2014). We found that
CSL overexpression in patient-derived CAFs similarly stabilized
the levels of p62 (Figure 5D), consistent with the reversion of
CAF phenotype after CSL overexpression (Procopio et al.,
2015).
CSL protein expression is negatively controlled by autophagy
through a mechanism involving a direct CSL-p62 protein associ-
ation. In turn, by decreasing the autophagic process, CSL func-
tions as a positive determinant of p62 expression levels, pointing
Figure 3. Endogenous p62 and CSL Proteins
Directly Interact in HDFs
(A and B) Proximity ligation assays (PLAs) for in situ
detection of CSL and p62 association in HDFs.
Assays were carried out in the presence or
absence of primary antibodies (A) or with HDFs
plus/minus siRNA-mediated CSL gene silencing
(B) as controls of specificity. Confocal microscopy
was used to examine red fluorescence PLA puncta
with concomitant DAPI staining of nuclei (blue). The
white frames indicate the enlarged areas to better
show PLA red puncta. Shown are representative
images and quantification of the average number of
puncta per cell, counting at least 30 cells in four
fields per conditions. p% 0.05, two-tailed unpaired
t test. Scale bars, 10 and 1 mm for enlargements.
Additional PLA images of p62 and CSL interaction
are provided in Figures S1A and S1B.
(C) Endogenous p62 and CSL proteins interact.
Immunoprecipitates from HDFs (strain SAN4) with
anti-CSL antibodies and non-immune immuno-
globulin Gs (IgGs) were analyzed, together with
total inputs by sequential immunoblotting with anti-
p62 and CSL antibodies. IgG light chains (LCs) are
indicated. A similar immunoprecipitation in another
HDF strain (SAN3) is shown in Figure S1C.
(D) p62 and CSL proteins directly interact. Re-
combinant CSL and p62 proteins were admixed
and incubated for 2 hr before immunoprecipitation
with either anti-CSL or anti-p62 antibodies or non-
immune IgGs, followed by immunoblot analysis
with anti-p62 antibodies (green) and anti-CSL an-
tibodies (red). IgG heavy chains (HCs) are indi-
cated.
(E) p62 interaction with CSL requires p62 C-termi-
nal region. Immunoblot analysis showed HEK293
transfected for 48 hr with expression vectors for
CSL-FLAG, GFP-p62, and a combination of CSL-
FLAG and GFP-p62 wild-type (WT) or GFP-p62
constructs with deletions of the N-terminal PB1
region, LIR, and C-terminal UBA region (as indi-
cated in the scheme) (Bjørkøy et al., 2005). Total
lysates were immunoprecipitated with anti-FLAG
antibodies, and blots were probed sequentially
with anti-GFP and anti-FLAG antibodies. The input
totals were analyzed by parallel immunoblotting as
control for the level of expression.to a self-reinforcing loop that could be targeted in CAF
activation.
DISCUSSION
In tumor stroma, CAFs affect all aspects of tumor evolution
(Dotto, 2014; Kalluri, 2016). Thus, targeting of CAFs represents
an emerging alternative therapeutic approach (Goruppi and
Dotto, 2013). Although several programs leading to the activa-
tion of CAFs have been elucidated, little is known about the
impact of the microenvironment on the turnover of key CAF reg-
ulators. CSL, a transcriptional repressor that mediates NOTCH
signaling, suppresses the gene expression programs, leading
to stromal senescence and CAF activation (Hu et al., 2012; Pro-copio et al., 2015). We report here that increased autophagy in-
creases CSL turnover, which is functionally relevant, because it
is associated with enhanced CAF effector expression. We find
a so far unsuspected interplay between CSL and p62 signaling
leading to CAF activation. p62 and CSL proteins associate
directly, and upon induction of autophagy, CSL is down-modu-
lated in stromal fibroblasts through a p62-dependent mecha-
nism. In CAFs, both CSL and p62 proteins are down-modulated
as a reflection of increased autophagy in these cells (Goruppi
et al., 2017).
Autophagy-enhancingconditions, suchasROS (Pavlidesetal.,
2010), hypoxia (Martinez-Outschoorn et al., 2010), and nutrient
starvation (Martinez-Outschoorn et al., 2017), can create a
pro-tumorigenic microenvironment rich in metabolic precursorsCell Reports 24, 3108–3114, September 18, 2018 3111
Figure 4. Autophagy Down-Modulates CSL Protein through a p62-Dependent Mechanism
(A and B) Immunoblot analysis of twoHDF strains (A) orMEFs (B) plus/minus p62 silencing by siRNA-mediated (A) or shRNA-mediated (B) RNA interference, either
left untreated (untr.) or treated with various pro-autophagic stimuli as in Figure 1A. Blots were sequentially probed with antibodies against p62, CSL, and ACTIN
antibodies.
(C) Immunoblot analysis with antibodies against p62, CSL, and ACTIN antibodies of MEFs plus/minus p62 gene disruption (/ and +/+) (Komatsu et al., 2006).
Cells were either left untreated (untr.) or treated with various pro-autophagic stimuli as in Figure 1A.
(D) Immunofluorescence analysis with CSL antibodies and DAPI of p62 +/+ and p62 / MEFs treated as in Figure 1A.directed from the stroma to the tumor (Lisanti et al., 2010; Zhao
et al., 2013). As for CSL (Hu et al., 2012; Procopio et al., 2015),
p62 protein and RNA levels are reduced in the stromal compart-
ment of several cancer types, with p62 deficiency, resulting
in CAF activation (Valencia et al., 2014). An unanswered question
was whether CSL and p62 are functionally connected. p62 is a
multifaceted adaptor protein involved in functions ranging from
nutrient or amino acid sensing and oxidative stress response
to selective autophagy (Katsuragi et al., 2015). The cargo
function of this protein is mediated by its ubiquitin-association
(UBA) domain, which is involved in target protein recognition,
and by its LIR, required for autophagosome recruitment and
degradation. p62 binds to key transcription factors like SMADs,
NRF2, and NF-kB to be degraded in autophagosome, with p62
being degraded in the process (Johansen and Lamark, 2011).
We have found that CSL is down-modulated by auto-
phagy, because genetic or pharmacologic inhibition of the pro-
cess blunts CSL degradation. Upon autophagy activation, the3112 Cell Reports 24, 3108–3114, September 18, 2018mechanism involves the physical and direct association to the
UBA domain of p62 adaptor. Another protein with key transcrip-
tion regulatory functions, GATA4, was shown to similarly go
through autophagic turnover mediated by p62 binding (Kang
et al., 2015).
Transcriptional control of autophagy is an area of active
investigation (Lapierre et al., 2015; Pietrocola et al., 2013) and
autophagy and mitophagy have been implicated in CAF con-
version (Goruppi et al., 2017; Kalluri, 2016; Martinez-Out-
schoorn et al., 2017). Besides being negatively regulated by
autophagy, down-modulation of CSL expression—as can result
from exogenous pro-carcinogenic stimuli such as UV or smoke
exposure (Menietti et al., 2016)—can by itself induce or re-
enforce the autophagic process (Goruppi et al., 2017). An inter-
esting possibility is that autophagy acts at multiple levels in
CAF activation, initiating gene expression by increasing CSL
turnover and by causing a cell-autonomous metabolic switch
upon the increase of autophagy and mitophagy after CSL
Figure 5. CSL Down-Modulation Is Linked to
Higher Autophagy in CAFs
(A) p62 and CSL levels are concomitantly down-
modulated in CAFs. Left: immunoblot with anti-p62,
anti-CSL, and anti-ACTIN antibodies in non-
matched HDF and CAF strains. Right: immunoblot
quantifications, n (HDF) = 2, n (CAF) = 4; *p < 0.05,
two-tailed unpaired t test. Each derived HDF strain
was marked by an operator identifier and progres-
sive numbers (SAN1 and SAN2). CAF strains were
marked only by a progressive number (CAF1–CAF4)
(Goruppi et al., 2017).
(B) CSL overexpression stabilizes p62 protein.
Immunoblot analysis showed HDFs (SAN3) stably
infected with a lentivirus for doxycycline-inducible
CSL expression (Procopio et al., 2015), plus/minus
doxycycline (200 ng/mL) for 3 days, under basal
conditions and after autophagy activation by serum
starvation (24 hr). Bafilomycin A1 was added for 2 hr
to monitor autophagic flux (Klionsky et al., 2016).
The arrow indicates the stabilized high-molecular
p62 band upon CSL induction. The blots were
sequentially probed with antibodies against p62,
LC3, CSL, and ACTIN.
(C) CSL overexpression inhibits autophagy gene
expression. RT-qPCR analysis with the indicated
genes, normalized to b-actin, in two HDF strains
stably infected with an inducible CSL-expressing
lentivirus, plus/minus CSL induction as in (B).
(D)CSL overexpression stabilizes p62 in CAFs. Immunoblot analysis showed antibodies against p62, CSL, and GAPDH of two patient-derived CAF strains (CAF1
and CAF16) expressing a doxycycline-inducible CSL and plus/minus (200 ng/mL) for 2 days.
Numbers refer to densitometry quantification of p62 in CSL-overexpressing versus noninduced control CAFs (folds of induction).loss of function (Goruppi et al., 2017). Counteracting CSL
down-modulation can stabilize p62, thereby enhancing the nu-
clear transcription regulatory function that this protein plays in
negative control of CAF activation (Duran et al., 2016; Valencia
et al., 2014).
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rabbit monoclonal anti CSL Cell Signaling Cat# 5313; AB_2665555
Rabbit monoclonal anti LC3B Cell Signaling Cat# 3868; AB_2137707
Rabbit monoclonal anti b-ACTIN Cell Signaling Cat# 5125; AB_1903890
Rabbit monoclonal anti SQSTSM/p62 Sigma Cat# P0067; AB_1841064
Rabbit anti CSL Procopio et al., 2015 N/A
Rabbit anti GFP Santa Cruz Cat# 8334; AB_641123
Rabbit anti ATG5 Epitomics Cat# 3167-1; N/A
Mouse monoclonal anti SQSTSM/p62 Santa Cruz Cat# 28359; AB_628279
Mouse monoclonal anti FLAG Sigma-Aldrich Cat# F3165; AB_259529
Mouse monoclonal anti GAPDH Santa Cruz Cat# 47724; AB_627678
Biological Samples
HDFs: discarded skin samples of abdominoplasty patients
at Massachusetts General Hospital
Dermatology, MGH, Boston, MA N/A
CAFs: surgically excised discarded skin SCC samples Dermatology, MGH, Boston, MA N/A
Chemicals, Peptides, and Recombinant Proteins
Recombinant human CSL Origene Cat# TP760429
Recombinant human p62 Enzo Cat# ENZ-PRT120-0050
Bafilomycin A1 EMD Millipore Cat# 19-149
3-methyladenine Sigma-Aldrich Cat# M9281-100MG
mTOR inhibitor KU0063794 Calbiochem Cat# CAS 938440-64-3
Carbonyl cyanide m-chloro-phenyl-hydrazone (CCCP) Calbiochem Cat# CAS 555-60-2
Puromycin Calbiochem Cat# CAS 58-58-2
Doxycycline Calbiochem Cat# CAS 24-390-14-5
Hiperfect Quiagene Cat# 301707
Lipofectamine 2000 Invitrogene Cat# 11668019
Liberase TL Roche Cat# 5401020001
Flag-MAGNETIC beads Sigma-Aldrich Cat# M8823-1ML
Donkey anti rabbit peroxidase conjugated Thermo Fisher Cat# NA934V
Donkey anti mouse peroxidase conjugated Thermo Fisher Cat# NA931V
Donkey anti rabbit Alexa 488 Invitrogen Cat# A 21206
Phalloidin RITC Sigma-Aldrich Cat# P1951-1MG
Critical Commercial Assays
Proximity ligation assay - Duolink Sigma-Aldrich Cat# DUO92101
Experimental Models: Cell Lines
MEFs Atg5 +/+ Kuma et al., 2004 N/A
MEFs Atg5 / Kuma et al., 2004 N/A
MEFs p62 +/+ Komatsu et al., 2006 N/A
MEFs p62 / Komatsu et al., 2006 N/A
HEK293 ATCC RRID: SCR_001672
Human primary dermal fibroblasts This paper SAN1
Human primary dermal fibroblasts This paper SAN2
Human primary dermal fibroblasts This paper SAN3
Human primary dermal fibroblasts This paper SAN4
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Human primary dermal fibroblasts This paper SAN5
Human primary dermal fibroblasts This paper SAN6
Human primary dermal fibroblasts This paper SAN8
Human cancer associated fibroblasts This paper CAF1
Human cancer associated fibroblasts This paper CAF2
Human cancer associated fibroblasts This paper CAF3
Human cancer associated fibroblasts This paper CAF4
Human cancer associated fibroblasts This paper CAF16
Oligonucleotides
siRNA scrambled control -Silencer Ambion Cat# 4390846; ID: N/A
siRNA targeting p62 -Silencer Ambion Cat# 4427037; ID: 16962
siRNA targeting CSL -Silencer Ambion Cat# 4392420; ID 24886
shRNA empty control N/A Sigma-Aldrich pLKO_TRC001
shRNA targeting p62 CCGGCCCTTTGTCTTGTAGTTGCAT
CTCGAGATGCAACTACAAGACAAAGGGTTTTTG
Sigma-Aldrich TRCN0000098615
shRNA targeting ATG5 CCGGGCCAAGTATCTGTCTATGA
TACTCGAGTATCATAGACAGATACTTGGCTTTTTG
Sigma-Aldrich TRCN0000099430
Oligonucleotides for PCR are listed in Table S1
Recombinant DNA
GFP-p62 Bjørkøy et al., 2005 N/A
GFP-p62 DPB1 Bjørkøy et al., 2005 N/A
GFP-p62 DUBA Bjørkøy et al., 2005 N/A
GFP-p62 DLIR Bjørkøy et al., 2005 N/A
CSL-FLAG Procopio et al., 2015 N/A
Myc-CSL inducible Procopio et al., 2015 N/A
Software and Algorithms
IMAGEJ NIH https://imagej.nih.gov/ij/
Prism 7 Graphpad software https://www.graphpad.comCONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to andwill be fulfilled by the LeadContact Gian Paolo
Dotto (paolo.dotto@unil.ch)
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human samples
Normal human skin samples and samples of squamous cell carcinoma (SCC) were obtained at the Department of Dermatology, Mas-
sachusetts General Hospital, as discarded parts not needed for diagnosis. All samples were processed as approved by the MGH
Institutional Review Board. The age/stage, sex and gender identity of the subjects was not available.
Cell culture and primary cell derivation
All the cells were routinely grown at 37 in a 5% CO2 incubator in DMEM Cellgro#15-017CV, 10%FBS, 2mMGlutamine and 100U/ml
penicillin, 100mg streptomycin. All cellular strains used were routinely checked for the absence of mycoplasma.
Normal HDFs were prepared from discarded skin samples of abdominoplasty patients at Massachusetts General Hospital (Bos-
ton, Massachusetts, USA) as in (Procopio et al., 2015). Each HDF strain was identified by letters recognizing the operator and a num-
ber, which are indicated in the different panels and listed in the Key Resources Table. For derivation of cancer associated fibroblasts
(CAFs), surgically excised discarded skin SCC samples were dissociated with Liberase TL (Roche) as in (Goruppi et al., 2017). The
isolated CAFs strains were validated in immunofluorescence as vimentin positive and pan Keratin negative. Each strain derived frome2 Cell Reports 24, 3108–3114.e1–e4, September 18, 2018
a patient was identified with a progressive number, which is indicated in the different panels and listed in Key Resources Table. The
information on sex/gender/age was not available.
METHOD DETAILS
Cell manipulation
RNA-mediated gene interference experiments were carried out with SilencerTM siRNA oligos from Ambion and Hiperfect reagents
(QIAGEN) (forCSL and p62), or, by using shRNA gene targeting lentiviral vectors fromSigma Aldrich (for p62 andATG5), as previously
described (Goruppi et al., 2017; Procopio et al., 2015). The lentiviral vectors (in the pLKO.1 backbone) were packaged using PEI
(Sigma) in actively growing 293 HEK cells in combination with pMD2.G/ /Rev/RRE plasmids. Virus containing supernatants were
collected 72h from transfection filtered to eliminate cell particulates and used to infect HDFs or MEFs in the presence of 10mg poly-
brene (Millipore). Cells were subsequently used for the experiments after puromycin selection (1mg/ml) for 48-72 h.
HDFs strains stably infected with a doxycycline-inducible lentiviral vector for Myc-tagged CSL in parallel with empty vector control
(Procopio et al., 2015) were treated for 3 days plus/minus doxycycline (200 ng ml1) before autophagy induction for 24h and analysis.
The list of the antibodies, reagents, cell lines, MEFs, HDFs, CAFs, siRNA and shRNA sequences used are in the Key Resources
Table.
Gene Expression analysis
Conditions for reverse transcription and quantitative cDNA amplification (RT–qPCR) have been previously reported (Goruppi et al.,
2017; Procopio et al., 2015). Total RNA was extracted using a Quiagene kit, and 750 ng reverse transcribed with iScript cDNA syn-
thesis kit (BioRad). Quantitative amplification was performed with a Roche real-time thermocycler and the expression of the genes
was normalized with BETA ACTIN. The oligonucleotides used in qPCR are provided in Table S1.
Autophagy studies, immunofluorescence and immunoblots
HDFs and MEFs autophagy was activated by incubating the cells in serum free or by adding to the culture medium (10%FBS) 10mM
mTOR inhibitor KU0063794 (Calbiochem) or 100nM carbonyl cyanidem-chloro-phenyl-hydrazone (CCCP) mitochondrial uncoupling
agent (Calbiochem) for 24h. Western blots and immunofluorescences were performed as in (Kong et al., 2010; Procopio et al., 2015).
Cells for protein analysis were washed in PBS ice cold then lysed in LDS-NuPAGE loading buffer 1x (Invitrogen) with phosphatase
and protease inhibitors before separation of the total cell lysates on 4%–12% Bis-Tris gels (Invitrogen). Equal amount was loaded
for each sample as assessed with separate Comassie blue stained gels and verified by sequential blotting of the same membrane
with a control antibody (TUBULIN, ACTIN or GAPDH, as indicated). For immunofluorescence cells were counted with a haemocy-
tometer and seeded on coverslips. The next day the HDFs or MEFs were treated as indicated to activate autophagy and thus fixed
after 20 h with 3% PFA in PBS for the analysis. Phalloidin and DAPI were used to counterstain the cytoskeleton and the nucleus
respectively. Slides were mounted with Fluomount-G (Southern Biotech) and analyzed using a Nikon Eclipse TE300 fluorescence
microscope.
Immunoprecipitations and protein interaction
The co-immunoprecipitation of p62 and CSL was performed from HDFs using a native lysis buffer (150mM NaCl, 50mMTris pH7,
1% Triton X-100, 10mM PMSF and PIC, Roche), in the presence of 4mg of anti CSL or NRS (Cell Signaling) and 40 ml Protein G mag-
netic beads (Life Technologies) for 4h at 4C. The complexes were washed 4 times in lysis buffer and eluted with SDS-running buffer.
For the interaction of CSL with p62 wt and deletion constructs, 3mg of CSL-Flag and 3mg of GFP tagged wild-type, DPB1, DUBA and
DLIR region (Bjørkøy et al., 2005) were transfected in 293 cells using PEI method. After 48h the cells were lysed in native lysis and the
immunoprecipitation carried out using 40ml Flag-MAGNETIC beads (Sigma). The complexes were washed 5 times in lysis buffer
before the sequential immunoblotting with GFP (Santa Cruz) and Flag M2 (Sigma) antibodies.
For the recombinant protein interaction, 500 ng of recombinant CSL (Origene) and p62 (Enzo) were diluted in 500 ml PBS and incu-
bated 2h at 4C on a rotor. The sample was split in two for over night incubation with 1mg of specific antibody against CSL (Cell
Signaling) or p62 (Sigma) and non-specific rabbit IgG respectively, as control. 25 ml Dynabeads (Invitrogen) were added for additional
4h at 4C with rotation. Bait and prey were immunoprecipitated using a magnet and washed 4 times with 500 ml PBS before boiling
with sample buffer and western blotting.
Proximity ligation assays (So¨derberg et al., 2006) were performed using Duolink PLA kit (Sigma) according to manufacturer’s pro-
tocol. Briefly, cells were fixed with 4% formaldehyde and permeabilized in 0.1% Triton X-100. After blocking with PLA blocking
solution, HDFs were incubated with primary antibody solution containing p62 (Santa Cruz) and CSL (Cell Signaling) antibodies
(both from Santa Cruz). After washing with PLA wash buffer, cells were incubated with PLA probes, anti-rabbit PLUS, anti-mouse
MINUS, then washed, ligated, amplified by rolling circle amplification. Images were obtained with a Nikon Eclipse Ti confocal
microscope.Cell Reports 24, 3108–3114.e1–e4, September 18, 2018 e3
QUANTIFICATION AND STATISTICAL ANALYSIS
Data are presented as mean ± SEM, mean ± SD, or as ratio among treated and controls, as indicated in the Figure legends. For gene
expression and functional testing assays, statistical significance of differences between experimental groups and controls was as-
sessed by two-tailed unpaired t test, as indicated in the figure legends. A value for p < 0.05 was considered as statistically significant.
For each experiment, two to three separate HDF strains were used in independent experiments. The CAFs from four independent
patients were used. The researchers were not blinded and no strain or result was excluded from the analysis.
DATA AND SOFTWARE AVAILABILITY
Unprocessed original imagedata have beendeposited toMendeleyData and are available at https://doi.org/10.17632/grw7vdjkdb.1.e4 Cell Reports 24, 3108–3114.e1–e4, September 18, 2018
